Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00
Provider: New Constructs, LLC
$25.00
Provider: Jefferson Research
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Amedisys Inc Issues FY 2013 Guidance Below Analysts' Estimates


Tuesday, 12 Mar 2013 07:00am EDT 

Amedisys Inc announced that for fiscal 2013, it expects net service revenue to be in the range of $1.425 billion to $1.45 billion. Diluted earnings per share (EPS) is expected to be in the range of $0.60 to $0.70 based on an estimated 31.5 million shares outstanding. According to I/B/E/S Estimates, analysts on an average were expecting the Company to report revenue of $1.51 billion and EPS of $0.77 for fiscal 2013. 

Company Quote

25.42
-0.37 -1.43%
1:00pm EST